|
|
|
Ottawa researchers continue to set international standards for reporting clinical trials
May 23,
2025
-
Nearly 30 years ago, the CONSORT statement transformed clinical trials around the world
|
|
|
|
|
|
Cracking cancer's code: Researchers find new way to slow ovarian tumour growth in mice
May 23,
2025
-
A new study published in Oncogene has uncovered a survival tactic of high-grade serous ovarian cancer (HGSOC) in mice: the suppression of Lats1 and Lats2, two genes that are essential for regulating cell growth and tumour formation.
|
|
|
|
|
|
New scientist profile: Dr. Ehsan Habibi sketches life with hyper-realistic precision
May 16,
2025
-
As an artist, Dr. Ehsan Habibi paints lush forests, bubbling streams and shiny pebbles that are so realistic they could be mistaken for photographs. It’s called “hyper-realism” and it’s a philosophy that he applies to science just as much as to art.
|
|
|
|
|
|
Small dose, big impact: Lower dose of blood thinner provides safer blood clot prevention in cancer patients
May 15,
2025
-
Thanks to new research published in the New England Journal of Medicine, people with cancer can now take a reduced dose of blood thinning medication to prevent recurring venous thromboembolism (VTE), a type of blood clot
|
|
|
|
|
|
International Clinical Trials Day: Three patient perspectives
May 13,
2025
-
This International Clinical Trials Day, let’s take a moment to recognize the incredible contributions of patient participants, the loved ones who support them, and the dedicated researchers, staff, and trainees who make it all possible.
|
|
|
|
See all news items | See only press releases | Search for news and experts by disease / specialty
|
|
|
Media contacts
Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca
|
